Aln G 1.0101

Major pollen allergen Aln g 1 Recombinant
Cat. No.
BT15569
Source
Sf9 insect cells.
Synonyms
Major pollen allergen Aln g 1, Allergen Aln g I, Aln g 1.
Appearance
Sterile Filtered clear solution.
Purity
Greater than 80.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant Major pollen allergen Aln g 1 produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 18,710 Dalton.
Aln G 1.0101 is expressed with a 10xHis tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
The primary pollen allergen, Aln g 1 (specifically Aln G 1.0101), is known to trigger allergic responses in individuals.
Description
Recombinant Major pollen allergen Aln g 1, synthesized in SF9 cells, is a glycosylated polypeptide chain with a calculated molecular mass of 18,710 Daltons. It features a 10xHis tag positioned at the N-terminus and undergoes purification using proprietary chromatographic methods.
Physical Appearance
A clear solution that has undergone sterile filtration.
Formulation
Aln G 1.0101 is provided in a buffer solution composed of 20mM HEPES at a pH of 7.9 and 6M Urea.
Stability
For optimal storage, maintain the product at a temperature of 4°C if the entire vial is intended for use within a timeframe of 2-4 weeks. For extended storage periods, store the product frozen at -20°C. It is advisable to minimize repeated freeze-thaw cycles.
Purity
SDS-PAGE analysis indicates a purity level exceeding 80.0%.
Immunological Functions
1. Demonstrates the ability to bind to human IgE antibodies. 2. Exhibits reactivity in immunodot assays conducted with panels of positive and negative sera.
Synonyms
Major pollen allergen Aln g 1, Allergen Aln g I, Aln g 1.
Source
Sf9 insect cells.
Molar Extinction Coefficient
7450; A280(1mg/ml)=0.398

Product Science Overview

Introduction

The major pollen allergen Aln g 1 is derived from the alder tree (Alnus glutinosa), which is widespread in North America and Central and Northern Europe . Aln g 1 belongs to the PR-10 (Pathogenesis-Related class 10) protein family, which includes several clinically relevant allergens known for their ability to bind hydrophobic ligands .

Structural Features

Aln g 1 is a glycosylated polypeptide with a calculated molecular mass of approximately 18,710 Daltons . The recombinant form of Aln g 1 is often expressed with a 10xHis tag at the N-terminus to facilitate purification through chromatographic techniques . The protein’s structure is characterized by a conserved fold typical of PR-10 proteins, which includes a seven-stranded antiparallel β-sheet and three α-helices .

Immunological Significance

Aln g 1 is a potent allergen that can act as a true sensitizer of the immune system . It has been shown to upregulate alarmins in epithelial cells, playing a crucial role in the sensitization process . The allergenicity of Aln g 1 is partly due to its ability to bind IgE antibodies from allergic patients . However, thermal denaturation of Aln g 1 can lead to a decrease in its IgE-binding capacity, suggesting that its structural integrity is essential for its allergenic properties .

Recombinant Aln g 1

Recombinant Aln g 1 is produced using various expression systems, including insect cells (SF9), to ensure proper glycosylation and folding . The recombinant protein is used in research to study the structural and immunological features of Aln g 1 and to develop hypoallergenic variants for allergen-specific immunotherapy .

Research and Applications

Recent studies have focused on understanding the allergenic and structural features of Aln g 1 through techniques such as qPCR, CD-spectroscopy, and ELISA assays . Site-directed mutagenesis has been employed to identify key residues involved in IgE binding and ligand interactions . These insights are crucial for developing hypoallergenic variants of Aln g 1, which could be used in allergen-specific immunotherapy to treat patients with alder pollen allergies .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.